When.com Web Search

  1. Ads

    related to: clinical trials for overweight women over 75

Search results

  1. Results From The WOW.Com Content Network
  2. Women's Health Initiative - Wikipedia

    en.wikipedia.org/wiki/Women's_Health_Initiative

    The Women's Health Initiative (WHI) was a series of clinical studies initiated by the U.S. National Institutes of Health (NIH) in 1991, to address major health issues causing morbidity and mortality in postmenopausal women. It consisted of three clinical trials (CT) and an observational study (OS).

  3. Cagrilintide/semaglutide - Wikipedia

    en.wikipedia.org/wiki/Cagrilintide/semaglutide

    CagriSema entered Phase III clinical trials in 2023. [6] In December 2024, Novo Nordisk announced the results of REDEFINE 1, one of their series of Phase III trials, testing weekly cagrilintide 2.4 mg and semaglutide 2.4 mg individually and together versus placebo in obese or overweight subjects with one or more comorbidities. [7]

  4. Template : Results of the Women's Health Initiative ...

    en.wikipedia.org/wiki/Template:Results_of_the...

    Results of the Women's Health Initiative (WHI) menopausal hormone therapy randomized controlled trials; Clinical outcome Hypothesized effect on risk Estrogen and progestogen (CEs Tooltip conjugated estrogens 0.625 mg/day p.o. + MPA Tooltip medroxyprogesterone acetate 2.5 mg/day p.o.) (n = 16,608, with uterus, 5.2–5.6 years follow up) Estrogen ...

  5. Why aren't there more Black women in clinical trials? Experts ...

    www.aol.com/lifestyle/why-arent-more-black-women...

    Despite representing 50% of the U.S. population, women are generally underrepresented in clinical trials. For example, women represent 38.2% of participants in cardiovascular clinical trials. When ...

  6. Anti-obesity medication - Wikipedia

    en.wikipedia.org/wiki/Anti-obesity_medication

    A prodrug of DNP, HU6, has been tested in clinical trials for weight loss and fatty liver disease. [ 22 ] Fibroblast growth factor-21 receptor agonists and drugs increasing FGF-21 activity are being investigated for obesity-related diseases; they can increase energy expenditure and several have been tested in humans.

  7. Obesity-associated morbidity - Wikipedia

    en.wikipedia.org/wiki/Obesity-associated_morbidity

    Death rate from obesity, 2019. Obesity is a risk factor for many chronic physical and mental illnesses.. The health effects of being overweight but not obese are controversial, with some studies showing that the mortality rate for individuals who are classified as overweight (BMI 25.0 to 29.9) may actually be lower than for those with an ideal weight (BMI 18.5 to 24.9). [1]

  1. Ad

    related to: clinical trials for overweight women over 75